Description: Cann Group Limited is an Australia-based company, which is engaged in the cultivation of cannabis for human medicinal and research purposes. The Company has facilities to cultivate medicinal cannabis. It also focuses on manufacturing medicinal cannabis products. It focuses on developing and supplying cannabis, cannabis resin and medicinal cannabis products into the Australian market. It also focuses on supplying to overseas markets. The Company has a cannabis research license and cannabis cultivation license. The cannabis cultivation license allows the Company to produce Australian grown material that can be prescribed for patient use. It has research and development, and cultivation facilities in Australia. It focuses on plant genetics; breeding; cultivation; extraction; analysis and production techniques to facilitate the supply of medicinal cannabis for a range of diseases and medical conditions.
Home Page: www.canngrouplimited.com
CAN Technical Analysis
American Funds
,
Phone:
800-421-4225
Officers
| Name | Title |
|---|---|
| Mr. Peter Crock M.B.A., MBA | Chief Exec. Officer |
| Ms. Deborah Ambrosini B.Com., F.C.A. | CFO & Company Sec. |
| Mr. Shane Duncan | Chief Operating Officer |
| Mr. Geoff Aldred | Chief Projects & Information Officer |
| Mr. Clive Fanning | Head of Investor Relations |
| Mr. Steven Notaro | Head of Legal |
Exchange: AU
Country: AU
Currency: Australian Dollar (A$)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Pharmaceuticals |
| GIC Sub-Industry: | Pharmaceuticals |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 1.0067 |
| Price-to-Sales TTM: | 7.0872 |
| IPO Date: | |
| Fiscal Year End: | June |
| Full Time Employees: | 0 |